Clinical characterization of hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors: a review of published cases

Zhiya Xua Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, People’s Republic of China

Huilan Lia Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, People’s Republic of China

Xinyi Yua Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, People’s Republic of China

Jia Luoa Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, People’s Republic of China

Zanling Zhanga Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, People’s Republic of China;b Institute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-8707-0487

Clinical characterization of hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors: a review of published cases

supplementary document.docx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical characterization of hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors: a review of published cases

supplementary document.docx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date